| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | PAYP | Japan | $19.73 | $0.00 | Buy | 9 | 2026 |
#2 | MMED | United States | $11.59 | $0.00 | Strong Buy | 10 | 2026 |
#3 | TOST | United States | $24.87 | $6,153,000,000.00 | Buy | 22 | 2021 |
#4 | AA | United States | $63.11 | $12,831,000,000.00 | Buy | 10 | 2016 |
#5 | AR | United States | $35.92 | $5,275,823,000.00 | Buy | 16 | 2013 |
#6 | EQT | United States | $56.06 | $8,644,211,000.00 | Buy | 21 | 1994 |
#7 | NFG | United States | $79.79 | $2,277,541,000.00 | Buy | 4 | 1997 |
#8 | CVNA | United States | $77.57 | $20,322,000,000.00 | Buy | 24 | 2017 |
#9 | GMED | United States | $77.46 | $2,938,931,000.00 | Buy | 14 | 2012 |
#10 | TMDX | United States | $67.90 | $605,494,000.00 | Buy | 9 | 2019 |
#11 | SHAK | United States | $70.26 | $1,445,306,000.00 | Buy | 26 | 2014 |
#12 | DAN | United States | $34.67 | $7,500,000,000.00 | Buy | 5 | 1998 |
#13 | FRPT | United States | $52.31 | $1,102,015,000.00 | Buy | 17 | 2014 |
#14 | INSP | United States | $44.11 | $82,050,000.00 | Buy | 16 | 2018 |
#15 | AORT | United States | $25.47 | $298,836,000.00 | Strong Buy | 5 | 1996 |
#16 | NVST | United States | $24.25 | $2,566,500,000.00 | Buy | 13 | 2019 |
#17 | ALHC | United States | $17.93 | $3,948,719,000.00 | Buy | 8 | 2021 |
#18 | STOK | United States | $32.60 | $184,420,000.00 | Strong Buy | 10 | 2019 |
#19 | PEGA | United States | $35.94 | $682,695,000.00 | Buy | 12 | 1996 |
#20 | ARQT | United States | $21.04 | $376,072,000.00 | Strong Buy | 6 | 2020 |
#21 | CLMT | United States | $32.36 | $4,137,100,000.00 | Strong Buy | 5 | 2024 |
#22 | REPX | United States | $33.25 | $3,038,000.00 | Strong Buy | 4 | 2003 |
#23 | ATRC | United States | $26.24 | $201,630,000.00 | Strong Buy | 7 | 2005 |
#24 | AMLX | United States | $14.64 | $380,786,000.00 | Strong Buy | 9 | 2021 |
#25 | IDYA | United States | $28.23 | $218,710,000.00 | Strong Buy | 16 | 2019 |
#26 | ARVN | United States | $10.10 | $262,600,000.00 | Buy | 19 | 2018 |
#27 | BSX | United States | $53.79 | $9,076,000,000.00 | Strong Buy | 22 | 2010 |
#28 | CSV | United States | $45.66 | $417,440,000.00 | Strong Buy | 4 | 1996 |
#29 | WK | United States | $51.10 | $884,568,000.00 | Strong Buy | 10 | 2014 |
#30 | TARS | United States | $61.44 | $451,360,000.00 | Buy | 6 | 2020 |
#31 | USFD | United States | $84.61 | $39,424,000,000.00 | Buy | 11 | 2016 |
#32 | MAMA | United States | $13.17 | $95,420,129.00 | Strong Buy | 5 | 2011 |
#33 | W | United States | $66.08 | $0.00 | Buy | 28 | 2014 |
#34 | CRTO | France | $16.48 | $2,296,692,000.00 | Strong Buy | 10 | 2013 |
#35 | ERAS | United States | $10.02 | $0.00 | Strong Buy | 12 | 2021 |
#36 | RIVN | United States | $14.34 | $5,387,000,000.00 | Buy | 21 | 2021 |
#37 | ZYME | United States | $23.92 | $105,965,000.00 | Strong Buy | 11 | 2022 |
#38 | PPL | United States | $35.80 | $9,042,000,000.00 | Buy | 13 | 2007 |
#39 | RLAY | United States | $12.70 | $15,355,000.00 | Strong Buy | 10 | 2020 |
#40 | IMAX | Canada | $35.40 | $410,212,000.00 | Strong Buy | 10 | 1997 |
#41 | MDT | Ireland | $75.96 | $33,537,000,000.00 | Buy | 21 | 2014 |
#42 | MRBK | United States | $18.22 | $6,316,000.00 | Strong Buy | 4 | 2018 |
#43 | RVLV | United States | $20.76 | $1,225,682,000.00 | Buy | 12 | 2018 |
#44 | CE | United States | $57.08 | $9,544,000,000.00 | Buy | 14 | 2004 |
#45 | FLS | United States | $71.07 | $0.00 | Strong Buy | 11 | 2006 |
#46 | OLLI | United States | $82.02 | $2,649,198,000.00 | Strong Buy | 13 | 2015 |
#47 | FTI | United States | $70.49 | $9,932,600,000.00 | Buy | 13 | 2016 |
#48 | NI | United States | $46.80 | $0.00 | Buy | 10 | 2018 |
#49 | PEG | United States | $77.18 | $12,168,000,000.00 | Buy | 12 | 1994 |
#50 | KTOS | United States | $57.77 | $751,900,000.00 | Strong Buy | 18 | 1999 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $100 to Buy (May 10, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.